Guidance: Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants under the Generic Drug User Fee Amendments

TitleGuidance: Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants under the Generic Drug User Fee Amendments
ToC Doc Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants under the Generic Drug User Fee Amendments
Docket Number2024-18636
Type Notice
Subject Guidance:
Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants under the Generic Drug User Fee Amendments
Publication Date2024-08-20
Last Updated Date 2024-08-19 08:15:48 -0400
Last Public Inspection2024-08-19
Filed At2024-08-19T08:45:00.000-04:00
PDF 2024-18636_PI.pdf (108465 bytes)
Download TXT / HTML / JSON
Number of Pages 6
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021